EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis

Preethi Chandrasekaran iD, Ralf Weiskirchen iD

International Journal of Molecular Sciences · 16.01.2024 · 25 (2) · 1109

DOI: 10.3390/ijms25021109 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 16.01.2024. Verfasst von Preethi Chandrasekaran und 1 weiteren Autor:innen. Beteiligte Einrichtung: UT Southwestern Medical Center Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Fatty Liver, Liver Neoplasms, Sterol Regulatory Element Binding Protein 1, Intracellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 92-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, German Cancer Aid, Interdisciplinary Centre for Clinical Research within the faculty of Medicine at the RWTH Aachen University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) is rapidly increasing worldwide at an alarming pace, due to an increase in obesity, sedentary and unhealthy lifestyles, and unbalanced dietary habits. MASLD is a unique, multi-factorial condition with several phases of progression including steatosis, steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Sterol element binding protein 1c (SREBP1c) is the main transcription factor involved in regulating hepatic de novo lipogenesis. This transcription factor is synthesized as an inactive precursor, and its proteolytic maturation is initiated in the membrane of the endoplasmic reticulum upon stimulation by insulin. SREBP cleavage activating protein (SCAP) is required as a chaperon protein to escort SREBP from the endoplasmic reticulum and to facilitate the proteolytic release of the N-terminal domain of SREBP into the Golgi. SCAP inhibition prevents activation of SREBP and inhibits the expression of genes involved in triglyceride and fatty acid synthesis, resulting in the inhibition of de novo lipogenesis. In line, previous studies have shown that SCAP inhibition can resolve hepatic steatosis in animal models and intensive research is going on to understand the effects of SCAP in the pathogenesis of human disease. This review focuses on the versatile roles of SCAP/SREBP regulation in de novo lipogenesis and the structure and molecular features of SCAP/SREBP in the progression of hepatic steatosis. In addition, recent studies that attempt to target the SCAP/SREBP axis as a therapeutic option to interfere with MASLD are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty LiverLiver NeoplasmsSterol Regulatory Element Binding Protein 1Intracellular Signaling Peptides and ProteinsMembrane ProteinsAnimalsHumansLipid MetabolismLipogenesis

Stichwörter der Autor:innen

MASLDSCAPSREBP1cde novo lipogenesisfatty acid synthesisinsulin resistancelipid metabolismliverpathogenesistherapytriglycerides

Substanzen

Sterol Regulatory Element Binding Protein 1SREBP cleavage-activating proteinSREBF1 protein, humanIntracellular Signaling Peptides and ProteinsMembrane Proteins

Autor:innen und Institutionen

  • UT Southwestern Medical Center Dallas, 5323 Harry Hines Blvd., Dallas, TX 75390, USA.
  • Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), Rheinisch-Westfälische Technische Hochschule (RWTH) University Hospital Aachen, D-52074 Aachen, Germany.

ORCID-Profile: Preethi Chandrasekaran, Ralf Weiskirchen

Förderung

  • Deutsche Forschungsgemeinschaft
  • German Cancer Aid
  • Interdisciplinary Centre for Clinical Research within the faculty of Medicine at the RWTH Aachen University
  • German Research Foundation
  • Deutsche Krebshilfe

Zitieren

APA

Chandrasekaran, P., & Weiskirchen, R. (2024). The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis. International Journal of Molecular Sciences, 25(2), 1109. https://doi.org/10.3390/ijms25021109

Vancouver

Chandrasekaran P, Weiskirchen R. The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis. International Journal of Molecular Sciences. 2024;25(2):1109. doi:10.3390/ijms25021109

BibTeX
@article{Chandrasekaran2024,
  author = {Chandrasekaran, Preethi and Weiskirchen, Ralf},
  title = {The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {2},
  pages = {1109},
  doi = {10.3390/ijms25021109}
}
Kostenlos starten →